Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Bionidi is an innovative platform driven by artificial intelligence that caters to Medical Affairs, scientific communications, and life sciences marketing teams. It empowers these teams to transform provided publications and sanctioned brand materials into various forms of scientific content, such as presentations, medical explainer videos, infographics, and e-learning resources. The platform's workflow integrates scientific storytelling with visual design and evidence mapping, enabling reviewers to assess the connections between content and its original sources effectively. Common projects include slide decks based on publications, explanations of scientific processes, educational materials for medical professionals, and tailored adaptations for diverse audiences. The importance of human scientific review and adherence to each organization's approval procedures remains a crucial aspect of the process. Currently, Bionidi is available for commercial use, and interested parties can arrange for a demonstration based on a relevant content brief to see its capabilities in action. This allows potential users to gain insights into how Bionidi can enhance their scientific communication efforts effectively.

Description

Cure AI represents a cutting-edge medical research platform that harnesses the power of artificial intelligence to grant users access to an extensive library of over 26 million scientific publications sourced from PubMed. With its AI-driven natural language processing capabilities, users can pose research questions in a conversational manner, which the system accurately decodes to return specific and relevant results. It also boasts sophisticated search filters that allow users to narrow down findings by factors such as journal, date of publication, and various other criteria, catering to individual research requirements. Additionally, Cure AI evaluates evidence based on its quality and significance, taking into account metrics like the journal's h5-index, citation tally, and the type of publication, thereby ensuring users obtain the most relevant and credible information available. The platform further enhances user experience by allowing easy transitions between AI-generated insights and original literature, streamlining the process of literature review and analysis. Moreover, it comes equipped with convenient citation tools that enable users to quickly copy or share references with just one click, simplifying the documentation process. Finally, the intuitive design of Cure AI encourages researchers to explore new avenues of inquiry with confidence and ease.

API Access

Has API No 

API Access

Has API No 

Screenshots View All

No images available

Screenshots View All

Integrations

PubMed No 

Integrations

PubMed Yes 

Pricing Details

Approximately $1,000 per complex-content project.
Free Trial No 
Free Version No 

Pricing Details

$15 per month
Free Trial No 
Free Version No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support No 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs No 
Webinars No 
Live Training (Online) No 
In Person No 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person No 

Vendor Details

Company Name

Bionidi

Founded

2025

Country

India

Website

www.bionidi.com

Vendor Details

Company Name

Cure AI

Website

www.askcureai.com

Product Features

Product Features

Alternatives

Alternatives

Anju MAX Reviews

Anju MAX

Anju Software